Cantor Fitzgerald Reaffirms Overweight Rating on UnitedHealth Group

Cantor Fitzgerald has reaffirmed its Overweight rating on UnitedHealth Group's stock, setting a price target of $495.00.

This implies a potential upside of around 27% for investors, as shares are currently trading at $388.28.

The firm cited the company's undervalued status and positive outlook in its analysis of the Medicare Advantage sector.

Cantor Fitzgerald noted that UnitedHealth appears to be well-positioned for a strong earnings season, driven by favorable medical loss ratios and robust Optum Health operating income.